Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant Influenza H5N1 Vaccine

recombinant influenza H5N1 vaccine · UMN Pharma Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Influenza H5N1 Vaccine, covering 2010-02-08 to 2010-02-08. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young Adults [Phase 2]

See pricing